Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangshen'an Granules for Diabetic Neurovascular Coupling Impairment
NCT06813274Phase 2Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Nov 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Tangshen'an in neurovascular coupling impairment (NVCI). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Tangshen'an
03
Conditions
neurovascular coupling impairment (NVCI)
Beyond the preview
Go deeper on NCT06813274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06813274.